L
Luca Steardo
Researcher at Magna Græcia University
Publications - 195
Citations - 7728
Luca Steardo is an academic researcher from Magna Græcia University. The author has contributed to research in topics: Bipolar disorder & Medicine. The author has an hindex of 45, co-authored 177 publications receiving 6304 citations. Previous affiliations of Luca Steardo include Seconda Università degli Studi di Napoli & Sapienza University of Rome.
Papers
More filters
Journal ArticleDOI
Gender differences in drug responses
TL;DR: This review summarizes gender differences (GDs) in drug response and considers whether sex has to be considered in order to improve drug safety efficacy and to optimize medical therapy both in men and women.
Journal ArticleDOI
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
Giuseppe Esposito,Caterina Scuderi,Marta Valenza,Giuseppina I. Togna,Valentina Latina,Daniele De Filippis,Mariateresa Cipriano,Maria Rosaria Carratù,Teresa Iuvone,Luca Steardo +9 more
TL;DR: Results showed that the blockade of PPARγ was able to significantly blunt CBD effects on reactive gliosis and subsequently on neuronal damage, which report the inescapable role of this receptor in mediating CBD actions.
Journal ArticleDOI
Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19.
TL;DR: The new coronvirus, classified as SARS-CoV-2 that emerged in Hubei province in China, causes a new coronavirus disease, which was termed COVID-19 by WHO on February 11, 2020.
Journal ArticleDOI
Cannabidiol in vivo blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression
Giuseppe Esposito,Caterina Scuderi,Claudia Savani,Luca Steardo,D. De Filippis,Pietro Cottone,Teresa Iuvone,Vincenzo Cuomo +7 more
TL;DR: The present study, performed in a mouse model of AD‐related neuroinflammation, was aimed at confirming in vivo the previously reported antiinflammatory properties of CBD.
Journal ArticleDOI
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation
Giuseppe Esposito,Elena Capoccia,Fabio Turco,Ilaria Palumbo,Jie Lu,Antonio Steardo,Rosario Cuomo,Giovanni Sarnelli,Luca Steardo +8 more
TL;DR: Because of its lack of toxicity, its ability in reducing inflammation and its selective PPARα action, PEA might be an innovative molecule to broaden pharmacological strategies against UC.